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SUMMARY
Takotsubo cardiomyopathy (TC), otherwise known 
as stress cardiomyopathy, is characterised by acute, 
transient left ventricular systolic dysfunction with apical 
ballooning in the absence of obstructive epicardial 
coronary stenosis. The presentation of TC mimics that 
of acute myocardial infarction. More recently there has 
been a shift towards thinking of TC as a ’microvascular 
acute coronary syndrome’. Our case is of an 82-year-old 
woman who presented with TC mimicking acute anterior 
ST elevation myocardial infarction in the context of 
sepsis. Slow flow noted in the left anterior descending 
artery prompted us to perform coronary physiology. 
Her fractional flow reserve was 0.91, with an index of 
myocardial resistance of 117 and a coronary flow reserve 
of 1.6. In combination these results are indicative of 
microvascular coronary dysfunction in the absence of 
significant epicardial stenosis.
BACkgRoUnd
Takotsubo cardiomyopathy (TC), otherwise known 
as stress cardiomyopathy, is characterised by acute, 
transient left ventricular (LV) systolic dysfunction 
with apical ballooning in the absence of obstructive 
epicardial coronary stenosis.1 The name derives 
from the pathognomonic shape of the ballooned LV 
on ventriculogram resembling a Japanese octopus 
trap.2 Colloquially it is known as ‘broken heart 
syndrome’ due to its association with acute physical 
or emotional stress. TC is most prevalent in post-
menopausal women, with this group accounting for 
up to 90% of cases.3 
The presentation of TC mimics that of acute 
myocardial infarction, often presenting with chest 
pain, cardiac enzyme elevation and ischaemic ECG 
changes (ranging from mild T wave inversion to 
widespread ST elevation). It accounts for approxi-
mately 2% of patients undergoing emergency coro-
nary angiography for acute coronary syndrome.4
The pathophysiology of TC is not yet fully 
understood. The association with emotional and 
physical stress naturally led investigators towards 
investigating the role of circulating catecholamines. 
Patients with TC have increased concentrations of 
plasma catecholamines that are counterintuitively 
even higher than those in patients suffering from 
ST elevation myocardial infarction (STEMI). These 
levels remain markedly elevated for days after 
symptom onset.5 There is ongoing debate regarding 
the mechanism of how this translates into acute LV 
dysfunction. One theory suggests direct toxicity 
of endogenous catecholamine causing myocardial 
necrosis similar to that observed in acute intracranial 
haemorrhage.6 Others suggest that the rapid stimu-
lation of adrenoceptors enhances cardiac inotropy 
and chronotropy with a secondary oxygen supply–
demand imbalance with resultant ischaemia.7
More recently there has been a shift towards 
thinking of TC as a ‘microvascular acute coronary 
syndrome’.8 Patients have angiographically slow 
coronary flow in the absence of epicardial coronary 
artery stenosis.9 The cause of this slow flow has been 
revealed to be acute microvascular impairment. We 
carried out a literature review using PubMed with 
the keywords ‘takotsubo’, ‘stress cardiomyopathy’, 
‘microvascular’, ‘IMR’ and ‘CFR’. The identified 
case reports and papers are summarised in table 1.
This is proposed to relate to primary micro-
vascular coronary spasm mediated by the afore-
mentioned increased concentrations of circulating 
catecholamines and increased levels of the potent 
vasoconstrictor endothelin-1 (which preferentially 
constricts the microcirculation).10 11 Intravenous 
adenosine has been shown to transiently improve 
myocardial perfusion, wall motion score index 
and LV ejection fraction in TC but not myocar-
dial infarction, suggesting that microvascular 
dysfunction plays a major role in the pathogen-
esis. Microvascular function has been shown to 
gradually improve with time. This correlates with 
improving LV function, and both have been shown 
to normalise at 1-month follow-up.12 13
Additionally, Giusca et al14 have published a case 
report of reversible epicardial coronary vasospasm 
in TC. Although epicardial vasospasm in TC is 
not commonly reported, this case may suggest the 
possibility of a spectrum of vasospastic responses, 
extending from microvascular to epicardial vaso-
spasm in extreme cases.
A recent study has also highlighted the role of 
inflammation in the pathogenesis of TC.15 It is 
currently uncertain whether this inflammation is a 
primary or secondary process.
CASe pReSenTATion
An 82-year-old woman was referred to her local 
district general hospital with 3 weeks of wors-
ening left leg cellulitis and confusion. She had a 
background of hypertension, paroxysmal atrial 
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fibrillation, corrected hypothyroidism, post-traumatic epilepsy, 
obesity and chronic bilateral lymphoedema with disseminated 
secondary eczema. She was clinically septic on arrival—febrile, 
tachycardic and hypotensive. She was treated with intravenous 
antibiotics. She was also noted to have an acute kidney injury and 
delirium. She responded well to initial treatment and avoided 
the need for inotropic support.
Over the coming week she had physical and biochemical 
improvement both in her cellulitis and acute kidney injury. Her 
delirium was slower to resolve and she remained intermittently 
confused. She was therefore transferred offsite to another district 
general hospital for a period of convalescence and rehabilitation 
prior to discharge. She was notably distressed and confused in 
the context of ongoing delirium and change of treatment team/
surroundings.
While in the rehabilitation ward, she developed acute severe 
chest pain. Her ECG (figure 1) was suggestive of an extensive 
anterior STEMI. She was discussed with and accepted by her 
nearest tertiary percutaneous intervention (PCI) centre for 
urgent coronary angiography.
Her biochemistry and haematology results are summarised in 
table 2. These are consistent with a modest extent of myocar-
dial necrosis. Of interest, we have bold-highlighted clinically 
relevant, abnormal results, including hypokalaemia, hypoalbu-
minaemia and systemic inflammation as revealed by C reactive 
protein (CRP). Interestingly, white cell and neutrophil counts 
were entirely normal.
On arrival her coronary angiogram surprisingly revealed 
smooth epicardial coronary arteries (figure 2A). There was 
however slow flow in her left anterior descending artery (LAD).
We proceeded to perform coronary physiology on her LAD 
(figure 3 and table 3).
This suggested that, although there was no flow-limiting 
epicardial coronary stenosis, there was evidence of increased 
microvascular resistance. A left ventriculogram was then 
carried out, revealing LV apical ballooning consistent with TC 
(figure 2B). Her echocardiogram supported the diagnosis of TC, 
showing evidence of severe LV systolic dysfunction with apical 
ballooning and akinetic mid to apical regions with preservation 
of the basal segments (figure 4).
A cardiac MRI (CMR) confirmed severely impaired LV 
function with akinetic mid to apical LV segments and apical 
ballooning (figure 5). There was evidence of myocardial oedema 
Table 1 Summary of the available published literature suggesting microvascular dysfunction in Takotsubo cardiomyopathy
Authors Journal Year evidence of microvascular dysfunction
Kurisu et al24 JACC (Journal of the American College of Cardiology) 2003 Abnormal TIMI frame counts (TFC) in all major coronary vessels in 28 patients.
Bybee et al25 AJC (American Journal of Cardiology) 2004 Abnormal TFC in all major coronary vessels in 16 patients.
Fazio et al26 J Clin Monit Comput (Journal of clinical monitoring and 
computing)
2010 Abnormal TFC in all major coronary vessels in 23 of 24 patients.
Daniels and Fearon27 CCI (Catheterization and Cardiovascular Interventions) 2011 Elevation of IMR reported in one case report.
Layland et al28 CRM (Cardiovascular revascularization medicine) 2012 Reversible elevation of IMR in one case report.
Khalid et al9 Int J Cardiol (International Journal of Cardiology) 2015 Corrected TFC in all major coronary vessels in 16 patients.
Warisawa et al29 J Circ (Circulation Journal) 2016 Reversible elevation of IMR in one case report.
Rivero et al12 JAMA Cardiology(Journal of the American Medical Association 
:Cardiology)
2017 Prospective demonstration of time-related improvement of IMR in 15 patients.
Loffi et al30 BioMed Res Int (Biomed research international) 2018 Retrospective analysis of TFC, blush grade and Quantitative myocardial Blush score (QuBE) 
score in 27 patients.
IMR, index of myocardial resistance. 
Figure 1 12-lead ECG showing ST marked anterior ST elevation 
(arrows) with Q waves.  aVF and aVL, augmented vector F and L. 
Table 2 Overview of the available laboratory data and blood 
testing
Blood test 
(reference range, 
units) t–5 hours t+0 hour t+1 hour t+8 hours t+17 hours
High sensitivity (Hs) 
troponin I (0–16, ng/L)
N/A 228 N/A N/A N/A
Troponin T (0–13 ng/L) N/A N/A N/A N/A 150
Sodium (133–146, 
mmol/L)
139 138 136 136 140
Potassium (3.5–5.3, 
mmol/L)
3.5 3.2 2.7 3.5 4.1
Urea (2.5–7.8, 
mmol/L)
3.9 4 3.8 3.7 3.9
Creatinine (40–130, 
μmol/L)
71 69 77 83 94
Bilirubin (<20, μmol/L) 8 8 6 6 5
Alanine 
Aminotransferase 
(ALT) (<50, U/L)
<6 <6 <6 <6 <6
Aspartate 
Aminotransferase 
(AST) (<40, U/L)
14 15 15 15 16
Alkaline Phosphatase 
(ALP) (30–130, U/L)
94 93 78 90 88
Albumin (35–50, g/L) 26 25 23 26 27
C reactive protein 
(0–10, mg/L)
61 59 42 46 45
Haemoglobin (115–
165, g/L)
140 139 130 N/A 137
White cell count 
(4.0–10.0, ×109/L)
9.4 9.4 9.37 N/A 9.66
Neutrophils (2.0–7.0, 
×109/L)
4.7 5 4.46 N/A 5.21
Platelet count (150–
410, ×109/L)
321 317 300 N/A 306
‘T’ represents the time of onset of chest pain.
Highlighted in bold are clinically relevant, abnormal results. 
N/A, not available. 
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with elevated native T1 and T2 relaxation times, especially 
marked in the akinetic mid to apical segments. There was subtle, 
non-specific epicardial late gadolinium enhancement noted in 
the LV apex in a non-coronary distribution (figure 6). In combi-
nation this pattern is consistent with TC. Additionally, the CMR 
shows evidence of bilateral pleural effusions and a rim of peri-
cardial fluid indicative of marked cardiac decompensation on 
presentation.
oUTCoMe And Follow-Up
Our patient returned to her district general hospital the day after 
her coronary angiogram. There she remained as an inpatient for 
a further 61 days while undertaking a prolonged programme of 
intensive rehabilitation due to frailty resulting from her critical 
illness with sepsis and TC. She ultimately returned to her func-
tional baseline at time of discharge. Unfortunately, 36 days after 
discharge, she was readmitted with septic shock secondary to 
severe bilateral bronchopneumonia. She died following a short 
hospital admission.
She did not have any repeat cardiac imaging following her 
index admission as she died prior to her appointment for 
follow-up echocardiogram. We are therefore unable to comment 
on the degree of residual LV dysfunction at the time of her death.
diSCUSSion
The combination of the above imaging modalities and coronary 
physiology confirmed the diagnosis of TC. Her trigger appears 
to have been a combination of physical stress resulting from her 
sepsis and emotional stress resulting from delirium.
Fractional flow reserve (FFR) is the pressure distal to a 
coronary stenosis divided by the aortic pressure. It is calcu-
lated during hyperaemia (typically pharmacologically induced 
with adenosine) to minimise vascular resistance to ensure the 
observed pressure is directly proportional to coronary flow. 
It represents epicardial coronary flow only. The ischaemic 
threshold is ≤0.80.16
Coronary flow reserve (CFR) is a measure of coronary vaso-
dilator capacity calculated by the ratio of maximum coronary 
blood flow to resting coronary blood flow. A pressure/therm-
istor-tipped guidewire is used to interpret multiple boluses of 
room temperature intracoronary saline to obtain coronary ther-
modilution curves and calculate the mean transit times. CFR 
is a well-established, prognostically validated measure of the 
vasodilator capacity of the coronary circulation, combining both 
epicardial and microvascular resistance. CFR may be estimated 
non-invasively and, as in this case, invasively. CFR may have 
limited test–retest repeatability and is strongly influenced by 
resting flow in addition to the response to hyperaemia. Notwith-
standing these methodological considerations, the CFR value 
recorded in our patient (1.6) is severely depressed and very likely 
to fairly represent substantially depressed vasodilator reserve at 
that time. In the context of a normal FFR, a low CFR is indica-
tive of microvascular dysfunction. The ischaemic threshold for 
CFR is ≤2.0.17–19
Figure 2 (A) Coronary angiogram showing smooth, obstructed left 
main stem, left anterior descending and circumflex arteries. (B) Left 
ventriculogram showing apical ballooning in keeping with Takotsubo 
cardiomyopathy. The arrows delineate the 5F pigtail catheter within 
the basal portion of the left ventricular cavity and the ballooning 
appearance in the left ventricular apex.
Figure 3 Coronary physiology testing aortic pressure (Pa), distal 
pressure (Pd), fractional flow reserve (FFR) and coronary flow 
reserve (CFR).
Table 3 Coronary physiology using pressure wire in our patient’s 
left anterior descending artery 
Test Value
ischaemic reference 
range
Resting Pd/Pa (distal pressure/aortic pressure) 0.93
Fractional flow reserve 0.91 <0.8
Coronary flow reserve 1.6 <2.0
Index of myocardial resistance 117 >25
Figure 4 Transthoracic echocardiogram in the apical four-chamber 
view during systole. Theright (RA) and left (LA) atria are labelled to 
assist orientation. There is left ventricular apical ballooning (arrow) and 
akinesis with preservation of the basal segments. 
copyright.
 o
n
 D
ecem
ber 13, 2019 at University of G
lasgow. Protected by
http://casereports.bmj.com/
BM
J Case Rep: first published as 10.1136/bcr-2019-229618 on 28 August 2019. Downloaded from
 
4 Morrow AJ, et al. BMJ Case Rep 2019;12:e229618. doi:10.1136/bcr-2019-229618
novel diagnostic procedure
The index of myocardial resistance (IMR) is a measure of 
microvascular resistance. It is defined as the distal coronary 
pressure divided by the inverse of the hyperaemic mean transit 
time. It is the minimum microvascular resistance during steady-
state, maximum hyperaemia. Unlike CFR, IMR is not influenced 
by resting conditions. IMR therefore specifically reflects micro-
vascular resistance within a target coronary artery. The normal 
range of IMR is <25.20 21
All three measurements can be taken quickly in the catheter 
laboratory using a single pressure/thermistor-tipped guidewire. 
The results can then be interpreted together to comment on both 
epicardial and microvascular coronary function (figure 7).
In this case the patient had impaired CFR and IMR with a 
normal FFR. This is indicative of microvascular dysfunction and 
is in keeping with the ‘microvascular acute coronary syndrome’ 
model of TC.
It is generally under-recognised in the medical community that 
TC is associated with considerable mortality. The International 
Takotsubo Registry, a consortium of 26 centres in Europe and the 
USA (n=1750), reported that 9.9% of patients with TC develop 
acute cardiogenic shock on presentation, with an overall inpa-
tient mortality of 4.1%.22 This is comparable with the outcomes 
for STEMI in the primary PCI era.23
Current standard of care is the establishment of traditional 
heart failure medications (ACE inhibitors and beta blockers) 
without any major randomised control trial (RCT) data to 
support this. Invasive coronary physiology (FFR/CMR/IMR) 
may provide an easily assessable, quantitative test of treatment 
efficacy.
Further research is required to test whether the severity 
of microvascular dysfunction at diagnosis relates to disease 
severity or mortality in TC. However the observed simultaneous 
improvement of coronary flow and LV dysfunction suggests this 
is an avenue worth exploring.13
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Figure 5 Cardiac MRI during systole revealing apical ballooning 
(arrow) and akinesis with preservation of the basal segments. Bilateral 
pleural effusions (arrows) reveal the patient’s overloaded fluid status on 
presentation. LA, left atrium; RA, right atrium. 
Figure 6 (A) Late gadolinium enhancement image of an apical four-
chamber slice on cardiac MRI showing a subtle, non-specific epicardial 
late gadolinium enhancement noted in the left ventricular (LV) apex in 
a non-coronary distribution. (B) T1 map of an apical four-chamber slice 
on cardiac MRI showing elevated native T1, especially marked in the 
akinetic mid to apical segments. The native T1 relaxation time in the LV 
apex is markedly elevated at 1258 ms in comparison with 939 ms in the 
basal LV segments. This pattern is indicative of myocardial oedema.
Figure 7 Summary of coronary physiology. CFR, coronary flow 
reserve; FFR, fractional flow reserve; IMR, index of myocardial 
resistance; Pa, aortic pressure; Pd, distal pressure.
learning points
 ► Takotsubo cardiomyopathy accounts for 2% of all acute 
coronary syndrome presentations and is associated with 
similar mortality to that of patients suffering from myocardial 
infarction in the era of primary percutaneous intervention.
 ► Takotsubo cardiomyopathy is associated with an acute, 
reversible increase in microvascular resistance that gradually 
improves with time.
 ► This temporal improvement in microvascular resistance 
correlates with improving left ventricular function.
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